Sign in to continue:

Thursday, July 30th, 2026

Cycurion, Inc. Announces Exchange and Restructuring Agreements with Noteholders and Amendment to Certificate of Incorporation – SEC Filing 8-K June 2026




Cycurion, Inc. 8-K Filing: Comprehensive Debt Restructuring and Equity Changes

Cycurion, Inc. Announces Comprehensive Debt Restructuring, Convertible Preferred Stock Issuance, and Amendments to Charter

Key Points from the 8-K Filing

  • Material Definitive Agreements: Cycurion, Inc. entered into a series of exchange and restructuring agreements with key noteholders, including IQ Financial, Inc., M2B Funding Corp., and Obsidian Associates, LLC.
  • Restructuring Details: The company converted outstanding principal and accrued interest from prior notes into new convertible promissory notes and Series H Convertible Preferred Stock, effectively consolidating and cancelling previous debt obligations.
  • Conversion Prices: Existing notes were converted at \$1.45 per share, while newly issued notes are convertible at \$1.05 per share. These rates are significant and could affect the dilution and pricing of Cycurion’s common stock.
  • Leak-Out Provisions: Shareholders receiving new shares are subject to resale limitations, restricting sales to no more than 5% of Cycurion’s average daily trading volume—an important mechanism to prevent large-scale dumping and price volatility.
  • Comprehensive Debt Restructuring: The agreements eliminate prior defaults, penalties, and accrued charges, potentially improving Cycurion’s financial health and balance sheet.
  • Unregistered Sales of Equity Securities: Convertible promissory notes and Series H Convertible Preferred Stock were issued without SEC registration, relying on exemptions (Section 4(a)(2), Regulation D, and Section 3(a)(9)).
  • Amendments to Charter: Cycurion authorized 3,000 shares of Series H Convertible Preferred Stock (\$0.0001 par value), with detailed terms covering voting rights, protective provisions, and conversion mechanics.
  • Series H Preferred Stock Details:
    • Voting Rights: Holders vote on an as-converted basis and on matters required by law or specified in the Certificate of Designation.
    • Protective Provisions: The company cannot alter rights, increase authorized shares, or amend charter documents affecting Series H without majority approval from holders.
    • Interest: Series H carries a 12% annual interest rate.
    • Conversion Floor: \$1.45 per share is the minimum conversion price for Series H.
  • Trading and Exchange Information: Cycurion’s common stock (“CYC”) and redeemable warrants (“CYCUW”) are listed on The NASDAQ Stock Market.
  • Emerging Growth Company: Cycurion is designated as an emerging growth company, which may impact regulatory requirements and investor perceptions.
  • Exhibits Filed: The filing includes the full text of agreements, promissory notes, and the Series H Certificate of Designation for investor review.

Investor-Relevant Details and Potential Price Sensitivity

  • Debt Restructuring Impact: The elimination of debt defaults, penalties, and accrued charges could significantly improve Cycurion’s financial position, potentially enhancing its attractiveness to investors and supporting share value.
  • Dilution Risk: The conversion of large amounts of debt into equity at set prices (\$1.45 and \$1.05) may lead to dilution of existing shareholders, especially if converted shares enter the market. The leak-out provision is intended to moderate this impact.
  • Preferred Stock Features: The new Series H Preferred Stock carries significant voting and protective rights, and a high interest rate (12%). These features may make the preferred stock attractive to institutional investors and could affect control dynamics.
  • Unregistered Securities: The issuance of securities under exemptions means limited immediate liquidity but also potential for future sales as restrictive legends are removed under Rule 144. Cycurion is committed to covering legal costs for legend removal, facilitating future liquidity for holders.
  • Conversion Mechanics and Floor Price: The \$1.45 floor for conversion into common stock sets a minimum conversion price, which may help support the share price, especially if the market trades near or above this level.
  • Trading Restrictions: The 5% leak-out provision restricts the pace at which converted shares can be sold, potentially reducing short-term volatility and protecting existing shareholders from rapid dilution.
  • Exhibit Transparency: Investors can access the full legal text of all restructuring agreements, promissory notes, and the Certificate of Designation—allowing for detailed due diligence.
  • Financial Statement Restatement Risks: Convertible notes contain default triggers linked to financial statement restatements, trading market compliance, and other operational events; these could impact share value if triggered.
  • Emerging Growth Status: Cycurion’s designation as an “emerging growth company” may exempt it from certain regulatory requirements, but also signals risk and opportunity for investors.

Conclusion

Cycurion, Inc.’s 8-K filing represents a significant and comprehensive restructuring of its outstanding indebtedness and equity structure. By consolidating debt, issuing new convertible instruments, and introducing preferred equity with robust shareholder protections, the company aims to stabilize its financial position and reduce prior liabilities. These actions are likely to be price sensitive, as they affect the company’s capital structure, dilution risk, and future liquidity. Investors should carefully review the terms of the new securities, conversion prices, voting and protective provisions, and the potential for future sales of unregistered shares.

The restructuring, leak-out provisions, and conversion floors are designed to minimize share price volatility and protect both new and existing shareholders. However, the potential for dilution and shifts in control dynamics should be closely monitored.

Disclaimer

This article is based on information disclosed in Cycurion, Inc.’s Form 8-K and accompanying exhibits. It is not investment advice. Investors should conduct their own due diligence and consult financial advisors before making investment decisions. The information herein may not reflect all risks or opportunities and is subject to change as Cycurion releases further disclosures.




View Cycurion, Inc. Historical chart here



MSP Recovery (MSPR) Files 8-K Announcing Creation of Direct Financial Obligation – April 2026

MSP Recovery, Inc. Announces Receipt of \$0.1 Million Advanc...

Accendra Health, Inc. 8-K Filing Details: Company Information, Address, and Voting Results (May 14, 2026)

Accendra Health, Inc. 8-K Report - Key Shareholder News ...